Agilisium
Transforming Life Sciences with Innovative Generative AI Solutions

Agilisium is a rapidly growing AWS Advanced Consulting Partner with data and analytics and DevOps competency. The company assists organizations in designing, constructing, migrating, and managing their application workloads to expedite their transition to the agile cloud, attain their desired business objectives, and expand into new global markets. Agilisium empowers its customers to leverage the full potential of AWS, enabling them to benefit from cost savings, increased efficiency, enhanced agility, and greater availability.

Agilisium has carved its niche by adopting a focused approach, choosing to be a master of one rather than a jack of all trades. With a strategic focus on AWS as its preferred AI technology platform, analytics as its technical capability, and life sciences as its targeted industry, Agilisium has positioned itself as a Ph.D. level expert in the realm of data, advanced analytics, and generative AI solutions.

The heart of Agilisium's story angle lies in its commitment to delivering value. The company emphasizes its mission to be enablers, leveraging generative AI and machine learning to solve complex problems in the healthcare, life sciences, and pharmaceutical industries.

“Unlike many organizations that offer services spread horizontally across various technologies, we stand out with our hyper-focused approach, honing in on cloud data analytics, advanced analytics, and generative AI to cater specifically to the life sciences industry,” says Raj Babu, CEO, Agilisium.

The company’s goal is to create innovative solutions by amalgamating generative AI and data analytics techniques with deep expertise in life sciences. This vision extends across the entire life science value chain, encompassing research and development, medical affairs, commercialization, and manufacturing, ultimately aiming to improve patient lives.

Agilisium's success in life sciences lies in its systematic approach to understanding the intricacies of the industry. The company breaks down the life sciences value chain into functional divisions, conducting in-depth analyses of each area. By engaging in regular workshops with clients, Agilisium collaborates on identifying key business questions, ensuring a co-creative model that aligns technology solutions with specific industry needs.

Central to Agilisium's success is its strategic partnership with AWS. By choosing AWS as its primary cloud platform, Agilisium has streamlined the development and deployment of its solutions. The collaboration leverages AWS services such as Amazon EMR for big data processing, Amazon QuickSight for data visualization, and AWS Glue for data governance.

This not only accelerates the speed to market for Agilisium's solutions but also ensures high value for its clients in the life sciences sector.

“We have developed a specialized framework for generative AI solutions tailored to the pharmaceutical industry, aligning with specific functional divisions within life sciences, ensuring a systematic and impactful approach,” says Dr. Amar Drawid, Chief AI Officer.

Agilisium's generative AI solutions cover a spectrum of use cases, including document searches, insights generation, and personalized customer engagement. The ability to create on-the-fly dashboards, conduct semantic searches, and offer innovative solutions such as Gene Inspector for omics experiments showcases the breadth of Agilisium's generative AI portfolio. The company's agility labs serve as innovation hubs, where over a hundred experts collaborate to develop cutting-edge solutions.

Unlike many organizations that offer services spread horizontally across various technologies, we stand out with our hyper-focused approach, honing in on cloud data analytics, advanced analytics, and generative AI to cater specifically to the life sciences industry

Recognizing the sensitivity of healthcare data, Agilisium places security and privacy at the forefront of its solution development. The company ensures that generative AI models operate within the customer's firewall, with strict governance policies and persona-based access controls. Agilisium's commitment to data governance, compliance, and adherence to regulatory guidelines emphasizes the trustworthiness of its solutions.

Agilisium leads the digital transformation wave, spearheading innovation in life sciences through its generative AI solutions on the AWS platform. With a strategic focus, a collaborative approach with clients, and a commitment to security and privacy, Agilisium is not just a service provider but an invaluable partner in driving positive change within the healthcare and pharmaceutical industries. As technology continues to advance, Agilisium remains dedicated to its mission of solving complex problems, one generative AI solution at a time.